Data Management Plan The DAC develops a data management plan and other documents necessary for the ACA submission. Please note that, in some cases, other data/variables may be required. For example, Part D (prescription pharmaceutical data) requires a specific variable justification. The DAC is responsible for tracking and documenting all DEA certificates and IRB media issued for each project with data stored on DAC servers. The DAC Director and the DAC Compliance Coordinator are available to auditors during the presentation of the DUA procedure. Project Collaborators Send a complete list of people (name and contact information) to the DAC Compliance Coordinator. Register all people who work with the data, write papers with the data and/or supervise someone who works with the data. 3. You are asking for Aary Research Files (RIF). Why this study does not allow the use of LDS files (Restricted data). Describe why you can only use RIF data to complete the study. For more information, see ResDAC. 2.1.
Please describe how this cohort meets the minimum required data. Specify the approximate size of the expected cohort (- Benes) to ensure that you do not exceed a 20% sample of the carrier file. 2. Have you ensured that your data request tells the minimum amount of data needed to achieve your research goals? List the data needed to complete the work volume set out in Section 1. The timeline for approval processes for CMS-DUA resDAC applications typically lasts at least 3 to 5 months between transmission and receipt of data. 2.2. List the files and years of CMS data requested at that time and explain how they are used in the scan. List all the “primary” CMS data (DUA reference 14049) you request, as well as all derivative files (reference for the AEA under which they are currently authorized) with which you wish to work.
Summary: 1. Summary of studies. Please complete this section by explaining in detail the scope of your project‘s work, which usually includes a language specific to the specific research objectives and objectives of the award. Please note that this should be the same amount of work that was submitted on the project review form. All changes to the workspace require up-to-date approval of the project review form. Once the AEA application is complete and the supporting documents provided by the DAC and the principal investigator, the following process will take place: 5. If you intend to apply for the Master Beneficiary Summary File‘s National Death Index, please complete the NDI supplement. Please contact the DAC Director if you would like to work with the National Death Index. 2.4. Please list all non-identifiable or non-CMS files that you wish to use for your analysis in relation to the above files. Please note that the DAC automatically lists other potential files you probably need for your study.
Note: The DAC Director and the DAC Compliance Coordinator are available to support this process. Please follow these instructions when preparing the study‘s RIF summary form. The instructions follow each section of the form. Is it possible to obtain individual authorization from Medicare/Medicaid recipients for your research? Tell me. The DAC will finish this section for you. Employee Checklist If you work with another institution, please contact the DAC Director.